Kamel, N., Rageh, F. (2019). Transfusion-Transmissible Infections: Seroprevalence among Donors in an Egyptian University Blood Bank. Suez Canal University Medical Journal, 22(1), 79-84. doi: 10.21608/scumj.2019.65380
Noha Kamel; Fatma Rageh. "Transfusion-Transmissible Infections: Seroprevalence among Donors in an Egyptian University Blood Bank". Suez Canal University Medical Journal, 22, 1, 2019, 79-84. doi: 10.21608/scumj.2019.65380
Kamel, N., Rageh, F. (2019). 'Transfusion-Transmissible Infections: Seroprevalence among Donors in an Egyptian University Blood Bank', Suez Canal University Medical Journal, 22(1), pp. 79-84. doi: 10.21608/scumj.2019.65380
Kamel, N., Rageh, F. Transfusion-Transmissible Infections: Seroprevalence among Donors in an Egyptian University Blood Bank. Suez Canal University Medical Journal, 2019; 22(1): 79-84. doi: 10.21608/scumj.2019.65380
Transfusion-Transmissible Infections: Seroprevalence among Donors in an Egyptian University Blood Bank
1Department of Clinical Pathology, Faculty of Medicine, Suez Canal University. Egypt
2Department of Endemic Diseases, Faculty of Medicine, Suez University, Egypt
Abstract
Background: Blood safety is facing a major challenge in Egypt, having a high recorded prevalence of Hepatitis C virus antibodies (HCV Ab). Egypt is facing a new era after three years of starting the implementation of the new antivirals for HCV infected individuals and 25 years of the compulsory vaccination program of hepatitis B. Aim: to estimate the seroprevalence of Hepatitis B and C viruses, HIV, and Trepenoma Pallidum antibodies among blood donors in a university blood bank. Materials and Methods: A retrospective study was conducted at Suez Canal University blood bank based on official records. 53138 donors’ data were analyzed from Jan 2015 to July 2018. Results: Among blood donors the prevalence of HCV Ab and HBsAg was 1.87 % and 0.97% respectively. No recorded positive cases of either HIV Ag-Ab or syphilis antibodies among the donated blood in this period. Percentages of positive HBsAg among family replacement donors (RD) and volunteer donors (VD) were decreased from 1.1% and 1.17 % in 2015 to 0.91% and 0.96% in 2018. Moreover, seropositivity for HCV Ab was declined in both RD and VD from 3% and 2.5% in 2015 to 1.3% and 1.4% in 2018, respectively. Conclusion: The prevalence of HCV and HBV is decreasing among blood donors and this may be attributed to the increasing awareness regarding blood-transmitted, hepatitis B vaccination, adherence to strict donation criteria, and introduction of oral direct acting antivirals.
View on SCiNiTO
Top